All In Biotech

Drug Trial Radar · NCT06285214

Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome

Multicenter, Randomized, Double-blind Placebo-controlled, Crossover Study to Investigate Effects of V117957 in Female Subjects With Interstitial Cystitis/Bladder Pain Syndrome

Last checked: Nov 20, 2026Latest source record: Mar 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

47

Actual

Start

May 26, 2022

Primary completion

Jan 28, 2025

Study completion Jan 28, 2025

Sponsor

Lead sponsor
Imbrium TherapeuticsIndustry
Sponsor type
Industry
Collaborators
Purdue Pharma LP
First posted
Feb 29, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with interstitial cystitis/bladder pain syndrome, compared to placebo.

Conditions

  • Interstitial Cystitis/Bladder Pain Syndrome

Interventions

  • V117957Drug

    V117957 1 mg - 1 tablet taken orally at bedtime.

  • PlaceboDrug

    Placebo to match V117957 tablets - 1 tablet taken orally at bedtime.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline for Worst Bladder Pain/Discomfort Scores Overnight / Over-the-dayTime frame: Assessed at Baseline, Weeks 2 and 8. Change from Baseline to Week 2 (Period 1) and Week 8 (Period 2) reported.

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Urology Centers of Alabama, PC

    Homewood, Alabama

  • Urological Associates of Southern Arizona

    Tucson, Arizona

  • Applied Research Center of Arkansas

    Little Rock, Arkansas

  • Investigational Site

    Escondido, California

  • Urology Group of Southern California

    Los Angeles, California

  • Hope Clinical Research, LLC

    Los Angeles, California

  • Tri Valley Urology Medical Group

    Murrieta, California

  • Accel Research Sites

    DeLand, Florida

  • Accel Research Site - Neurostudies

    Decatur, Georgia

  • Providea Health Partners LLC

    Evergreen Park, Illinois

  • Otrimed Clinical Research

    Edgewood, Kentucky

  • Southern Clinical Research Associates

    Metairie, Louisiana

  • Ochsner Louisiana State University Health Shreveport - Regional University

    Shreveport, Louisiana

  • Chesapeake Urology Research Associates

    Owings Mills, Maryland

  • Boston Clinical Trials

    Boston, Massachusetts

  • Bay State Clinical Trials, Inc.

    Watertown, Massachusetts

  • Revive Research Institute, Inc

    Dearborn Heights, Michigan

  • CentraCare - Urology Clinic

    Sartell, Minnesota

  • Adult & Pediatric Urology P.C.

    Omaha, Nebraska

  • AccuMed Research Associates

    Garden City, New York

  • Manhattan Medical Research Practice

    New York, New York

  • Unified Women's Clinical Research-Lyndhurst Clinical Research

    Winston-Salem, North Carolina

  • MetroHealth System

    Cleveland, Ohio

  • MidLantic Urology

    Bala-Cynwyd, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.